{
    "organizations": [],
    "uuid": "9792f934f4074c4c2a466d0be1d32c7acf56b0f3",
    "author": "",
    "url": "https://www.reuters.com/article/brief-miragen-therapeutics-announces-ini/brief-miragen-therapeutics-announces-initiation-of-second-phase-1-clinical-trial-of-mrg-110-idUSASC09YIX",
    "ord_in_thread": 0,
    "title": "BRIEF-MiRagen Therapeutics Announces Initiation Of Second Phase 1 Clinical Trial Of MRG-110",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1, 2018 / 11:21 AM / Updated 13 minutes ago BRIEF-MiRagen Therapeutics Announces Initiation Of Second Phase 1 Clinical Trial Of MRG-110 Reuters Staff 1 Min Read\nMay 1 (Reuters) - miRagen Therapeutics Inc:\n* MIRAGEN THERAPEUTICS ANNOUNCES INITIATION OF SECOND PHASE 1 CLINICAL TRIAL OF MRG-110 Source text for Eikon: Further company coverage:",
    "published": "2018-05-01T14:19:00.000+03:00",
    "crawled": "2018-05-01T14:43:51.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "announces",
        "initiation",
        "second",
        "phase",
        "clinical",
        "trial",
        "reuters",
        "staff",
        "min",
        "read",
        "may",
        "reuters",
        "miragen",
        "therapeutic",
        "inc",
        "miragen",
        "therapeutic",
        "announces",
        "initiation",
        "second",
        "phase",
        "clinical",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}